Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of hypertension.

× No keyword cloud information.

19 in total

Review 1. The metabolic syndrome.

Authors: Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal: Endocr Rev Date: 2008-10-29 Impact factor: 19.871

Review 2. Pharmacological and non-hormonal treatment of hot flashes in breast cancer survivors: CEPO review and recommendations.

Authors: Sylvain L'Espérance; Suzanne Frenette; Anne Dionne; Jean-Yves Dionne
Journal: Support Care Cancer Date: 2013-02-23 Impact factor: 3.603

Review 3. A Comparison of Vasodilating and Non-vasodilating Beta-Blockers and Their Effects on Cardiometabolic Risk.

Authors: Icilma V Fergus; Kenneth L Connell; Keith C Ferdinand
Journal: Curr Cardiol Rep Date: 2015-06 Impact factor: 2.931

Review 4. Update on blood pressure control and renal outcomes in diabetes mellitus.

Authors: Mark Henry Joven; Robert J Anderson
Journal: Curr Diab Rep Date: 2015-07 Impact factor: 4.810

5. Reductions in systolic blood pressure with liraglutide in patients with type 2 diabetes: insights from a patient-level pooled analysis of six randomized clinical trials.

Authors: Vivian A Fonseca; J Hans Devries; Robert R Henry; Morten Donsmark; Henrik F Thomsen; Jorge Plutzky
Journal: J Diabetes Complications Date: 2014-01-21 Impact factor: 2.852

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of hypertension.

Review 1. The metabolic syndrome.

Review 2. Pharmacological and non-hormonal treatment of hot flashes in breast cancer survivors: CEPO review and recommendations.

Review 3. A Comparison of Vasodilating and Non-vasodilating Beta-Blockers and Their Effects on Cardiometabolic Risk.

Review 4. Update on blood pressure control and renal outcomes in diabetes mellitus.

5. Reductions in systolic blood pressure with liraglutide in patients with type 2 diabetes: insights from a patient-level pooled analysis of six randomized clinical trials.

Review 6. Hypertension in infancy: diagnosis, management and outcome.

Review 7. Cardiovascular therapies and associated glucose homeostasis: implications across the dysglycemia continuum.

8. INVEST revisited: review of findings from the International Verapamil SR-Trandolapril Study.

Review 9. Optimal use of beta-blockers in high-risk hypertension: a guide to dosing equivalence.

10. Thiazide-induced dysglycemia: it's time to take notice.